Aspivix is a pioneering FemTech company dedicated to modernizing women’s healthcare worldwide by developing innovative medical devices like carevix®, designed to transform gynecological procedures through safer and less painful solutions that enhance quality of care and empower women to take control of their health.
carevix® is Aspivix’s clinically proven cervical stabilizer, featuring soft-suction technology as a modern and gentler alternative to the traditional cervical tenaculum. In a multicenter randomized controlled trial published in Contraception (2023), carevix® significantly reduced pain and bleeding during IUD placement compared to the tenaculum.
carevix® has received FDA clearance, CE-Mark, MHRA, and ANVISA approval, and is available for commercialization in Switzerland, the U.S. (Los Angeles, Orange County, New York), UK, and Benelux. The device has also earned recognition as one of TIME magazine’s Best Inventions of 2024 and was honored with the iF Design Award 2022, underscoring its impact and innovative design.

For more information, visit www.aspivix.com.
To order carevix® online, visit myaspivix.us.

Industries
FemTech, Healthcare, Women's Healthcare

Office Locations

Los Angeles